SGD Pharma is a world leader in the pharmaceutical glass packaging industry.

Apave is a market leader in the field of technical, environmental, human and digital risk management.

PAI MMF was raised entirely virtually and is above its €700m target and original €800 million hard cap, which was increased following significant investor interest.

MyFlower is a leading European flower and gift digital platform, which operates the Interflora brand in key European markets including France, Denmark, Iberia and Italy.

Apleona has more than 20,000 employees, managing tens of thousands of buildings and offices in over 30 countries across Europe.

Both companies benefit from high calibre management teams with a strong track record in product innovation, operational excellence, and building long-term customer relationships.

PAI will contribute its extensive international resources and its long-standing experience in the food market to accelerate the company’s new strategic business plan.

Ralph brings three decades of corporate, capital market and consulting experience as PAI continues to reinforce its presence in the region.

The appointment of Marc Boullier as Managing Director follows a number of senior hires over the last year to bolster the PAI Performance Group, which oversees operational transformation programmes across the firm’s portfolio and supports due diligence.